Guidelines for off-label use of anti-tuberculosis drugs

Certain anti-tuberculosis drugs carry known ototoxicity (hearing-damage) risk, making TB-treatment guidelines peripherally relevant to audiologists involved in ototoxicity monitoring programmes, but this specific guideline does not address hearing outcomes.